LoQus23 Therapeutics nominates first-in-class oral drug candidate for Huntington’s disease
Earendil Labs to collaborate with Sanofi on bispecific antibodies for autoimmune diseases
Insilico Medicine announces $888m collaboration with Servier
Small chip predicts drug side effects and acute kidney injury
FDA approves generalised myasthenia gravis drug
Breast cancer vaccine endpoints met with 74% immune response
Lilly to build $6bn Alabama facility
PsiThera unveiled with $47.5m funding to advance oral medicines
Rapid diagnostic breakthrough against Klebsiella
Pan Cancer T raises €10m for first-in-human trial of novel TCR-T cell therapy for triple-negative breast cancer
Vivacta Bio shows promising results for in vivo CAR-T therapy in non-Hodgkin’s lymphoma
OTR Therapeutics raises $100m for global transformative therapies